All In MedTech

FDA Clearance Tracker · P160054-S053

HeartMate 3 Left Ventricular Assist System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 29, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 29, 2023

Approved

Time to decision

179 days

Received Apr 3, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P160054-S053
Device name
HeartMate 3 Left Ventricular Assist System
Applicant location
Pleasanton, CA
Received
Apr 3, 2023
Decided
Sep 29, 2023
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P160054

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code DSQ

FDA's approval statement

As written in FDA's record.

Approval for an alternate final sterilization site located at Centerpiece S. De R.L De C.V, Bulevar La Encantada Industrial, Parque Industrial El Florido, Seccion La Encantada #11530, Tijuana, Baja California, Mexico 22250

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.